Reboxetine in the treatment of bulimia nervosa
by
Castilho SM, Costa LH.
Instituto de Psiquiatria da Faculdade de Medicina
da Universidade de Sao Paulo. Sao Paulo, SP, Brasil.
Rev Bras Psiquiatr. 2003 Jun;25(2):100-2


ABSTRACT

There is a substancial body of literature demonstrating the efficacy of selective serotonin reuptake inhibitors antidepressants (SSRI) in reducing binge eating and vomiting frequency in Bulimia Nervosa. Good therapeutic response to noradrenergic agents, like desipramine and reboxetine, though not frequently reported in literature, has already been demonstrated. This case report describes the treatment of Bulimia Nervosa with reboxetine (4 to 8 mg/day) and its favorable therapeutic results.


Bulimia
Efficacy
Reboxetine
Noradrenaline
NARIs and SSRIs
Reboxetine: structure
Reboxetine and the elderly





Refs
and further reading

HOME
HedWeb
Nootropics
erythroxylum-coca.com
Future Opioids
BLTC Research
MDMA/Ecstasy
Superhapiness?
Utopian Surgery?
The Abolitionist Project
The Hedonistic Imperative
The Reproductive Revolution
Critique of Huxley's Brave New World

The Good Drug Guide
The Good Drug Guide

The Responsible Parent's Guide
To Healthy Mood Boosters For All The Family